Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Long-Term Liabilities (Tables)

v3.20.4
Accrued Expenses and Long-Term Liabilities (Tables)
 3 Months Ended
Mar. 31, 2020
Accrued Expenses And Long-term Liabilities  
Schedule of Other Accrued Expenses

Other accrued expenses consisted of the following as of March 31, 2020 and December 31, 2019:

 

    As Restated     As Restated  
    March 31, 2020     December 31, 2019  
      (unaudited)          
Accrued royalties   $ 2,101     $ 1,934  
Contingent consideration     602       502  
Operating lease liability     1,251       1,321  
Financing lease liability     160       184  
Deferred revenue     354       457  
Payable to CGI     888       888  
Accrued sales and marketing - diagnostics     167       197  
Accrued lab costs - diagnostics     104       163  
Accrued professional fees     1,064       1,399  
Taxes payable     327       403  
Unclaimed property     565       565  
All others     1,056       1,463  
Total other accrued expenses   $ 8,639     $ 9,476  

Schedule of Long Term Liabilities

Long-term liabilities consisted of the following as of March 31, 2020 and December 31, 2019:

 

    March 31, 2020   December 31, 2019
    (unaudited)    
Warrant liability   $ 55     $ 82  
Uncertain tax positions     4,146       4,081  
Deferred revenue     258       269  
Other     104       141  
Total other long-term liabilities   $ 4,563     $ 4,573